These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 9022411)

  • 1. [ACE-inhibitors: the indication spectrum grows wider].
    Fortschr Med Suppl; 1996; 178():1-10. PubMed ID: 9022411
    [No Abstract]   [Full Text] [Related]  

  • 2. Expert consensus document on angiotensin converting enzyme inhibitors in cardiovascular disease. The Task Force on ACE-inhibitors of the European Society of Cardiology.
    López-Sendón J; Swedberg K; McMurray J; Tamargo J; Maggioni AP; Dargie H; Tendera M; Waagstein F; Kjekshus J; Lechat P; Torp-Pedersen C;
    Eur Heart J; 2004 Aug; 25(16):1454-70. PubMed ID: 15302105
    [No Abstract]   [Full Text] [Related]  

  • 3. [Therapy with ACE inhibitors. What kind of risk make them indispensible?].
    Kleber FX
    MMW Fortschr Med; 2000 Nov; 142(46):44-5. PubMed ID: 11132312
    [No Abstract]   [Full Text] [Related]  

  • 4. Clinical evidence of dose-dependent interaction between aspirin and angiotensin-converting enzyme inhibitors.
    Fisman EZ; Grossman E; Motro M; Tenenbaum A
    J Hum Hypertens; 2002 Jun; 16(6):379-83. PubMed ID: 12037691
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ACE inhibitors as cardioprotective agents.
    Young JB
    Am J Manag Care; 2002 Jun; 8(9 Suppl):30-7. PubMed ID: 12099326
    [No Abstract]   [Full Text] [Related]  

  • 6. [Use of aspirin in patients taking angiotensin converting enzyme inhibitors].
    Altin T; Kiliçkap M
    Anadolu Kardiyol Derg; 2007 Dec; 7 Suppl 2():14-9. PubMed ID: 18160362
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New opportunities in cardiovascular patient management: a survey of clinical data on the combination of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers.
    Weber MA
    Am J Cardiol; 2007 Aug; 100(3A):45J-52J. PubMed ID: 17666198
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ACE inhibitors, diabetes and cardiovascular disease.
    Gazis A; Page SR; Cockcroft JR
    Diabetologia; 1998 May; 41(5):595-7. PubMed ID: 9628279
    [No Abstract]   [Full Text] [Related]  

  • 9. [Efficacy of angiotensin-converting enzyme inhibitors in secondary prevention].
    Ceconi C; Mastrorilli F; Squasi PA; Gaitani S; Guardigli G; Ferrari R
    Ital Heart J; 2005 Nov; 6 Suppl 7():5S-13S. PubMed ID: 16485512
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Endothelium--a new target for a therapeutic action of angiotensin-converting enzyme inhibitors].
    Karpov IuA
    Ter Arkh; 2004; 76(6):94-6. PubMed ID: 15332589
    [No Abstract]   [Full Text] [Related]  

  • 11. Interactions of angiotensin-converting enzyme, kinins and nitric oxide in circulation and the beneficial effects of ACE inhibitors in cardiovascular diseases.
    Magen E; Viskoper RJ
    Isr Med Assoc J; 2000 Dec; 2(12):929-34. PubMed ID: 11344778
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The angiotensin II receptor blockers: opportunities across the spectrum of cardiovascular disease.
    Weber MA
    Rev Cardiovasc Med; 2002; 3(4):183-91. PubMed ID: 12556752
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Angiotensin receptor blocker often a valuable alternative to ACE inhibitors].
    Partanen J
    Duodecim; 2003; 119(13):1193-6. PubMed ID: 12908180
    [No Abstract]   [Full Text] [Related]  

  • 14. ACE inhibitors and the arterial wall. Introduction.
    Frishman WH
    Postgrad Med; 2000 Oct; 108(5 Suppl):3. PubMed ID: 19667534
    [No Abstract]   [Full Text] [Related]  

  • 15. ACE inhibitors in high risk cardiovascular patients: a new hope from the HOPE study.
    Gambhir DS
    Indian Heart J; 2000; 52(2):127-8, 211. PubMed ID: 10893889
    [No Abstract]   [Full Text] [Related]  

  • 16. Calcium-channel antagonists in cardiovascular disease.
    Holdright DR
    Br J Hosp Med; 1997 Jun 4-17; 57(11):552-6. PubMed ID: 9307671
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ACE inhibitors--revisited.
    Sathyamurthy I; Jayanthi K
    J Assoc Physicians India; 2000 Jul; 48(7):715-8. PubMed ID: 11273508
    [No Abstract]   [Full Text] [Related]  

  • 18. ACE inhibitors for all--'Hope' for the heart and failure for the kidneys?
    Goldsmith D
    J Hum Hypertens; 2001 Mar; 15(3):147-51. PubMed ID: 11317197
    [No Abstract]   [Full Text] [Related]  

  • 19. Absence of association between angiotensin I-converting enzyme (ACE) DD genotype and the frequency of ACE inhibitor therapy.
    Sigusch HH; Surber R; Vogt S; Müller S; Hoffmann A
    Pharmazie; 1997 Jul; 52(7):565-6. PubMed ID: 9266596
    [No Abstract]   [Full Text] [Related]  

  • 20. [The long way of angiotensin-converting enzyme inhibitors in the fight against cardiovascular diseases].
    Ferrari R; Ambrosio G; Chiariello M
    Ital Heart J; 2005 Nov; 6 Suppl 7():3S-4S. PubMed ID: 16485511
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.